|
Volumn 345, Issue 12, 2010, Pages 1663-1684
|
Synthesis and biological activity of ester and ether analogues of α-galactosylceramide (KRN7000)
|
Author keywords
Ester analogues of galactosylceramide; Glycolipid; Glycosylation; iNKT cells; KRN7000
|
Indexed keywords
AMIDE GROUPS;
BIOLOGICAL ACTIVITIES;
ETHER GROUP;
GLYCO LIPIDS;
INKT CELLS;
KRN7000;
METHOXY;
AMIDES;
ESTERS;
ETHERS;
GLYCOSYLATION;
ESTERIFICATION;
1 (TERT BUTYLDIMETHYLSILYLOXY) 2 (4 METHOXYBENZYLOXY) 11 OCTADECYN 3,4 DIOL;
1 (TERT BUTYLDIMETHYLSILYLOXY) 3,4 O ISOPROPYLIDENE 11 OCTADECYN 2 OL;
1 (TERT BUTYLDIMETHYLSILYLOXY) 3,4 O ISOPROPYLIDENE 2 (4 METHOXYBENZYLOXY) 11 OCTADECYNE;
1 (TETRAHYDRO 2'H PYRAN 2' YLOXY) 6 TRIDECYNE;
1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL;
1,2 DI TERT BUTYLDIMETHYLSILYLOXY 3,4 O ISOPROPYLIDENEDECAN 10 OL;
1,3 O [BENZYLIDENE] 2 (4 METHOXYBENZYLOXY) 11 OCTADECYN 4 OL;
10 BENZYLOXY 1 TERT BUTYLDIMETHYLSILYLOXY 3,4 O ISOPROPYLIDENE 5 DECENE 2 OL;
10 BENZYLOXY 1,2 DI TERT BUTYLDIMETHYLSILYLOXY 3,4 O ISOPROPYLIDENEDECENE;
10 BROMO 1,2 DI TERT BUTYLDIMETHYLSILYLOXY 3,4 O ISOPROPYLIDENEDECANE;
2 (4 METHOXYBENZYLOXY) 11 OCTADECYN 1,3,4 TRIOL;
2 BENZOYLOXY 1 (TERT BUTYLDIMETHYLSILYLOXY) 3,4 O ISOPROPYLIDENE 11 OCTADECYNE;
2 HEXACOSANOYLOXY 3 HYDROXY 4 METHOXYOCTADECYL ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HEXACOSANOYLOXY 3,4 DIHYDROXY 11 OCTADECYNYL ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HEXACOSANOYLOXY 3,4 DIHYDROXYOCTADECYL ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HEXACOSANOYLOXY 3,4 O ISOPROPYLIDENE 11 OCTADECYNYL 4,6 O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL)ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HEXACOSANOYLOXY 3,4 O ISOPROPYLIDENE 11 OCTADECYNYL 4,6 O BENZYLIDENE ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HEXACOSYLOXY 3,4 O ISOPROPYLIDENE 11 OCTADECYNYL 4,6 O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL)ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HYDROXY 3,4 O ISOPROPYLIDENE 11 OCTADECYNYL 4,6 O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL)ALPHA DEXTRO GALACTOPYRANOSIDE;
2 HYDROXY 3,4 O ISOPROPYLIDENE 11 OCTADECYNYL 4,6 O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL)BETA DEXTRO GALACTOPYRANOSIDE;
3,4 DIHYDROXY 2 HEXACOSANOYLOXYOCTADECYL 6 OMETHYL ALPHA DEXTRO GALACTOPYRANOSIDE;
3,4 DIHYDROXY 2 HEXACOSYLOXY 1 OCTADECYL ALPHA DEXTRO GALACTOPYRANOSIDE;
3,4 DIHYDROXY 2 HEXACOSYLOXY 11 OCTADECYNYL ALPHA DEXTRO GALACTOPYRANOSIDE;
3,4 O ISOPROPYLIDENE 11 OCTADECYN 1,2 DIOL;
4 HEXACOSANOYLOXY 2,3 DIHYDROXY 11 OCTADECYNYL ALPHA DEXTRO GALACTOPYRANOSIDE;
4 METHYLPHENYL 4,6 O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL) 1 THIO BETA DEXTRO GALACTOPYRANOSIDE;
4,5 ANHYDRO 1,3 O BENZYLIDENE 2 O (4 METHOXYBENZYL)DEXTRO ARABINITOL;
4,6O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL)ALPHA,BETA DEXTRO GALACTOPYRANOSE;
TRICHLOROACETIMIDOYL 4,6 O BENZYLIDENE 2,3 DI O (4 METHOXYBENZYL) ALPHA DEXTRO GALACTOPYRANOSIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL CELL;
ARTICLE;
CELL ACTIVATION;
DRUG ACTIVITY;
DRUG SYNTHESIS;
MOUSE;
NATURAL KILLER T CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS;
X RAY CRYSTALLOGRAPHY;
ANIMALS;
ESTERS;
ETHERS;
GALACTOSYLCERAMIDES;
INTERFERON-GAMMA;
INTERLEUKIN-4;
MICE;
MOLECULAR CONFORMATION;
NATURAL KILLER T-CELLS;
STEREOISOMERISM;
|
EID: 77955653859
PISSN: 00086215
EISSN: None
Source Type: Journal
DOI: 10.1016/j.carres.2010.05.003 Document Type: Article |
Times cited : (38)
|
References (34)
|